This guide explains how UK human medicines are categorised for sale and how other regulatory controls fit around those categories. It covers the main rules and practical checks, but it is not a substitute for the full legislation or advice on a specific medicine. Exact requirements depend on the product, its authorisation, supply route and UK nation.
1. Product identity, authorisation and legal status
Medicine regulation attaches to a specific product—not just an active ingredient. Brand or generic name, strength, dosage form, route, pack and authorisation all matter. A generic and a branded product may contain the same active ingredient but are separate product presentations; do not assume their authorisation, classification, manufacturer, pack or availability is identical.
Most medicines placed on the UK market need an applicable marketing authorisation. The authorisation sets out approved product information, including the product’s quality, safety and efficacy basis, permitted indications, dose and warnings. Other statutory registrations or authorisations exist for defined product types, including traditional herbal and homeopathic medicines; each route has its own requirements and evidence basis. A product without the relevant authorisation may only be supplied through a lawful, restricted route when its conditions are met.
The MHRA can change a medicine’s supply classification after review, but a classification change is product-specific. “POM” answers how the product may be supplied; “authorised” answers whether that particular product has permission to be placed on the market. They are related but distinct questions.
MHRA: marketing authorisations ↗ · MHRA: medicine reclassification ↗ · MHRA: traditional herbal registration ↗ · MHRA: herbal and homeopathic medicines ↗2. The general rule: a proper prescription is required
Under regulation 214, a person may not sell or supply a POM except in accordance with a prescription given by an appropriate practitioner. The Regulations identify practitioner categories, including doctors, dentists and specified independent or supplementary prescribers. Whether a particular professional may prescribe a particular medicine depends on their legal prescribing status, competence, scope and any medicine-specific restrictions. Prescribers must make an individual clinical decision; a request, questionnaire or online consultation does not automatically entitle someone to a prescription.
There are specific legal exceptions—for example, certain emergency pharmacy supplies, patient group directions and supplies in defined healthcare settings. These are conditional exceptions, not general permission to buy a POM without appropriate checks.
Human Medicines Regulations 2012, regulation 214 ↗ · Specific statutory exemptions, regulations 223 onwards ↗3. What makes a prescription valid
The legal requirements include who issued the prescription, its date and required prescriber and patient details. The prescription must identify the medicine and relevant directions and meet the applicable form and signature requirements. Regulation 219 provides for certain electronic prescriptions when its conditions are met; an image, email or online form is not automatically a valid prescription. Prescription rules for controlled drugs can add stricter particulars and conditions. A prescriber or pharmacist can explain what applies to a particular prescription.
Human Medicines Regulations 2012, regulations 217–219 ↗4. Clinical assessment, dispensing and supply
Prescribing and dispensing are distinct professional steps. A lawful prescriber assesses whether treatment is appropriate and issues a prescription when they decide to do so. The dispensing pharmacist must satisfy the applicable legal requirements and exercise professional judgement before supply. They may need to contact the prescriber, ask for clarification, check safety or refuse supply. Having a prescription does not guarantee a specific brand, quantity or immediate supply; stock, clinical suitability, legal restrictions and local arrangements may affect the outcome.
Follow the directions on your own prescription and dispensing label. Do not change a dose, share prescription medicine, use another person’s prescription or stop a regular medicine without appropriate clinical advice. Seek urgent help if you think you have taken a dangerous amount or are having a severe reaction.
Sale and supply rules for POMs ↗5. Limited exceptions are not a general route to purchase
The Regulations contain specific exemptions and exceptional supply arrangements. For example, a pharmacist may make an emergency supply in defined circumstances only when the statutory conditions are met; different conditions apply depending on whether the request comes from a prescriber or a patient. Other exemptions cover specified healthcare professionals, patient group directions and institutional settings. Some medicines—particularly controlled drugs—are excluded from or restricted under some exceptions. A patient cannot require a pharmacy to use an exemption, and the pharmacist must decide whether the legal conditions are satisfied.
Human Medicines Regulations 2012, exemptions in Part 12, Chapter 3 ↗ · Example: emergency supply at a patient’s request, regulation 225 ↗6. Buying medicine online
For an online seller, check the exact website address in the MHRA register of authorised online sellers—not just a logo, search result, social media account or marketplace listing. The register helps confirm whether a website is authorised to sell medicines online; it does not endorse a particular medicine, verify a prescription, guarantee product authenticity or assess suitability for you. A legitimate online clinical service should make clear who is prescribing and dispensing, how to contact them, and how your health information and follow-up care are handled. Avoid sellers offering prescription medicines without a proper prescription pathway or selling products with unclear origin.
Search the MHRA register of authorised online sellers ↗7. Controlled drugs have additional, schedule-dependent rules
Some prescription medicines are also controlled drugs under the Misuse of Drugs legislation. The schedules impose different controls. Depending on the drug and schedule, additional requirements can concern prescription wording and particulars, who may prescribe, when or how much may be supplied, repeat or instalment supply, safe custody, registers and record retention. The requirements are not interchangeable across schedules, and exceptions exist. Do not rely on the words “controlled drug” alone to determine the rules: check the exact active substance, preparation, schedule and current legislation.
Misuse of Drugs Regulations 2001 (Great Britain) ↗ · Misuse of Drugs Regulations (Northern Ireland) 2002 ↗8. Unlicensed medicines and imports
A product without the relevant UK authorisation is not the same as a routinely authorised UK medicine. A restricted “specials” route can permit supply to meet an individual patient’s special clinical need when the legal conditions are met and a responsible prescriber orders it. The route is not for ordinary retail choice or general consumer purchase. Unlicensed products may not have been assessed by the MHRA for safety, quality and efficacy in the same way as authorised medicines. Importing or distributing a medicine may require appropriate licences and MHRA notifications. A foreign brand, overseas pack, online listing or matching ingredient does not prove that the exact product is authorised in the UK.
Human Medicines Regulations 2012, regulation 167 ↗ · MHRA guidance on unlicensed medicines ↗ · MHRA guidance on importing medicines ↗10. Check the product, seller and rules that apply where you live
Before acting on a product listing, verify the exact product and pack through authoritative UK medicine information, check the online seller on the MHRA register, and ask a pharmacist or prescriber about prescription and supply requirements. Regulatory arrangements can differ between Great Britain and Northern Ireland, and some rules depend on local NHS services or professional regulators. The sources linked here are starting points; the legislation and regulator guidance—not this summary—are authoritative.
MHRA products database ↗ · GPhC pharmacy and professional registers (Great Britain) ↗11. Packaging, patient leaflets and ongoing safety
Medicine packaging and patient information leaflets carry product-specific information and must meet applicable legal requirements, subject to product-specific exceptions. Check that the name, strength and directions match what was prescribed and supplied, and read the leaflet before use. Authorisation holders and regulators monitor medicines after they reach the market; patients and healthcare professionals can report suspected side effects or other medicine safety problems to the MHRA Yellow Card scheme.
Human Medicines Regulations 2012, Part 13 (packaging and leaflets) ↗ · Report a medicine safety concern to Yellow Card ↗